Medicare Enrolled

Dr. Mark Saxon, D.O.

Psychiatry · Kingston, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
480 PIERCE STREET, Kingston, PA 18704
5707181996
In practice since 2006 (20 years)
NPI: 1255389326 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saxon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saxon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Saxon

Dr. Mark Saxon is a psychiatry specialist in Kingston, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Saxon performed 2,680 Medicare services across 829 unique beneficiaries.

Between the years covered by Open Payments, Dr. Saxon received a total of $32,033 from 46 pharmaceutical and/or device companies across 1046 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Saxon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in PA $32,033 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,680
Medicare services
Top 1% in PA for psychiatry
829
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~134 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,481 $61 $96
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
284 $49 $80
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
261 $61 $110
Psychotherapy session, 45 min
A 45-minute session of psychotherapy involving talk therapy to address emotional, behavioral, or mental health concerns.
212 $71 $123
Psychotherapy, 30 minutes
A 30-minute session of psychotherapy involving talk therapy to address mental health concerns.
135 $54 $77
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
128 $87 $135
Psychotherapy session, 1 hour
A one-hour psychotherapy session involving talk therapy to address mental health concerns.
96 $101 $161
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
59 $129 $200
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $39 $105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$32,033
Total received (2018-2024)
Avg $4,576/year across 7 years
Top 3% in PA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,046
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,023 (53.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,010 (46.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,085
2023
$3,066
2022
$2,546
2021
$1,729
2020
$1,068
2019
$6,995
2018
$13,544

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$464
Teva Pharmaceuticals USA, Inc.
$454
Otsuka America Pharmaceutical, Inc.
$393
ABBVIE INC.
$320
Alkermes, Inc.
$287
Neurocrine Biosciences, Inc.
$207
Lundbeck LLC
$200
Corium, LLC
$176
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$137
Axsome Therapeutics, Inc.
$114
BioXcel Therapeutics, Inc.
$56
Indivior Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$47
Sage Therapeutics, Inc.
$42
E.R. Squibb & Sons, L.L.C.
$41
Bausch Health US, LLC
$27
Vanda Pharmaceuticals Inc.
$25
IRONSHORE PHARMACEUTICALS INC.
$17
Novo Nordisk Inc
$15
Supernus Pharmaceuticals, Inc.
$13
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$12,243
Allergan Inc.
$5,746
Otsuka America Pharmaceutical, Inc.
$1,734
Janssen Pharmaceuticals, Inc
$1,554
Neurocrine Biosciences, Inc.
$1,399
Teva Pharmaceuticals USA, Inc.
$1,291
Alkermes, Inc.
$1,108
Lundbeck LLC
$770
ABBVIE INC.
$706
Sunovion Pharmaceuticals Inc.
$675
AbbVie Inc.
$639
ITI, Inc.
$416
Vanda Pharmaceuticals Inc.
$385
Neos Therapeutics, LP
$365
Corium, LLC
$345
Axsome Therapeutics, Inc.
$339
Bausch Health US, LLC
$290
Shire North American Group Inc
$259
Supernus Pharmaceuticals, Inc.
$165
Indivior Inc.
$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$137
Ironshore Pharmaceuticals Inc.
$125
JAZZ PHARMACEUTICALS INC.
$119
Merck Sharp & Dohme Corporation
$110
Eisai Inc.
$93
Noven Pharmaceuticals, Inc.
$70
Almatica Pharma LLC
$68
Noven Therapeutics, LLC
$68
Allergan, Inc.
$65
Avanir Pharmaceuticals, Inc.
$64
Merck Sharp & Dohme LLC
$62
IDORSIA PHARMACEUTICALS US INC
$60
BioXcel Therapeutics, Inc.
$56
Sage Therapeutics, Inc.
$42
E.R. Squibb & Sons, L.L.C.
$41
Jazz Pharmaceuticals Inc.
$41
Vertical Pharmaceuticals, LLC
$34
Neuronetics, Inc.
$30
Alfasigma USA, Inc.
$29
OWP Pharmaceuticals, Inc.
$27
EISAI INC.
$25
ACADIA Pharmaceuticals Inc
$17
IRONSHORE PHARMACEUTICALS INC.
$17
Novo Nordisk Inc
$15
Adlon Therapeutics L.P.
$15
Biohaven Pharmaceutical Holding Company Ltd.
$12
Top 3 companies account for 61.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · FANAPT · Fanapt · HETLIOZ · Hetlioz · IGALMI · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · NUPLAZID · NURTEC ODT · PERSERIS · QELBREE · QUVIVIQ · Qelbree · RELEXXII · REXULTI · SECUADO · SERTRALINE HCL · SPRAVATO · SUBVENITE · SUNOSI · Subvenite · Sunosi · TRINTELLIX · Trintellix · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · Vivitrol 380 mg · WELLBUTRIN · WELLBUTRIN XL · Wegovy · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for psychiatry in PA.

Looking for a psychiatry specialist in Kingston?
Compare psychiatrists in the Kingston area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
50
Per 100K population
15.3
County median income
$62,321
Nearest hospital
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
12.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Saxon is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with speaking/promotional industry engagement in the top 3% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Saxon experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Saxon performed 1,481 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saxon receive payments from pharmaceutical companies?
Yes. Dr. Saxon received a total of $32,033 from 46 companies across 1,046 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saxon's costs compare to other psychiatrists in Kingston?
Dr. Saxon's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saxon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →